Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Wu, Xiao ^a   Rabkin Aikawa, Elena ^b   Guleserian, Kristine J ^a   Perry, Tjorvi E ^a   Masuda, Yutaka ^a   Sutherland, Fraser W H ^a   Schoen, Frederick J ^b   Mayer Jr , John E ^a   Bischoff, Joyce ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood vessels; Polyglycolic acid poly L lactic acid; Tissue engineering

Indexed keywords

CADHERIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LACTIC ACID; POLYGLACTIN; POLYGLYCOLIC ACID; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ARTICLE; BIODEGRADABILITY; BLOOD VESSEL; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL STRAIN HL 60; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROVASCULATURE; PHENOTYPE; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

ABSORBABLE IMPLANTS; ANTIGENS, CD; ANTIGENS, CD34; BLOOD CELLS; BLOOD VESSELS; CELL AGING; CELL DIVISION; CYTOKINES; ENDOTHELIUM, VASCULAR; FETAL BLOOD; GLYCOPROTEINS; HUMANS; INFLAMMATION MEDIATORS; LACTIC ACID; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PEPTIDES; PHENOTYPE; POLYGLYCOLIC ACID; POLYMERS; STEM CELLS; TISSUE ENGINEERING;

EID: 3242714097     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01232.2003     Document Type: Article

References (37)

1. Aframian DJ, Redman RS, Yamano S, Nikolovski J, Cukierman E, Yamada KM, Kriete MF, Swaim WD, Mooney DJ, and Baum BJ. Tissue compatibility of two biodegradable tubular scaffolds implanted adjacent to skin or buccal mucosa in mice. Tissue Eng 8: 649-659, 2002.
2. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK, and Libby P. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97: 2433-2444, 1998.
3. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, and Dimmeler S. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024-1032, 2003.
4. Bompais H, Chagraoui J, Canron X, Crisan M, Liu XH, Anjo A, Tolla-Le Port C, Leboeuf M, Charbord P, Bikfalvi A, and Uzan G. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 103: 2577-2584, 2003.
5. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, and Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 29: 1517-1524, 1995.
6. Burger PE, Coetzee S, McKeehan WL, Kan M, Cook P, Fan Y, Suda T, Hebbel RP, Novitzky N, Muller WA, and Wilson EL. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100: 3527-3535, 2002.
7. Darland DC and D'Amore PA. Cell-cell interactions in vascular development. Curr Top Dev Biol 52: 107-149, 2001.
8. Dvorin EL, Jacobson J, Roth SJ, and Bischoff J. Human pulmonary valve endothelial cells express functional adhesion molecules for leukocytes. J Heart Valve Dis 12: 617-624, 2003.
9. Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, Debatin KM, Waltenberger J, and Beltinger C. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58: 478-486, 2003.
10. Fargeas CA, Corbeil D, and Huttner WB. AC133 antigen CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells 21: 506-508, 2003.
11. + umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br J Haematol 119: 516-524, 2002.
12. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, and Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 102: III44-III49, 2000.
13. Kanayasu-Toyoda T, Yamaguchi T, Oshizawa T, and Hayakawa T. CD31 (PECAM-1)-bright cells derived from AC133-positive cells in human peripheral blood as endothelial-precursor cells. J Cell Physiol 195: 119-129, 2003.
14. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, and Mayer JE Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7: 1035-1040, 2001.
15. Kim BS and Mooney DJ. Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res 41: 322-332, 1998.
16. + cell selection for ex vivo expansion of hematopoietic stem cells. J Hematother Stem Cell Res 10: 273-281, 2001.
17. Kraling BM and Bischoff J. A simplified method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors. In Vitro Cell Dev Biol Anim 34: 308-315, 1998.
18. Kraling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, Darveau RP, Mulliken JB, Corless CL, and Bischoff J. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 148: 1181-1191, 1996.
19. Lee H, Cusick RA, Browne F, Ho Kim T, Ma PX, Utsunomiya H, Langer R, and Vacanti JP. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation 73: 1589-1593, 2002.
20. Lin Y, Weisdorf DJ, Solovey A, and Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000.
21. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, and Buck DW. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021, 1997.
22. Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP, and Langer R. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials 17: 115-124, 1996.
23. Nor JE, Peters MC, Christensen JB, Sutorik MM, Linn S, Khan MK, Addison CL, Mooney DJ, and Polverini PJ. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 81: 453-463, 2001.
24. Ochoa ER and Vacanti JP. An overview of the pathology and approaches to tissue engineering. Ann NY Acad Sci 979: 10-35, 2002.
25. + cells identifies a population of functional endothelial precursors. Blood 95: 952-958, 2000.
26. Peters MC, Polverini PJ, and Mooney DJ. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 60: 668-678, 2002.
27. Rabkin E, Hoerstrup SP, Aikawa M, Mayer JE Jr, and Schoen FJ. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis 11: 308-314, 2002.
28. Rafii S and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712, 2003.
29. Rehman J, Li J, Orschell CM, and March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
30. Reyes M, Dudek A, Jahagirdar B, Koodle L, Marker PH, and Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346, 2002.
31. Schechner JS, Nath AK, Zheng L, Kluger MS, Hughes CC, Sierra-Honigmann MR, Lorber MI, Tellides G, Kashgarian M, Bothwell AL, and Pober JS. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci USA 97: 9191-9196, 2000.
32. Shirota T, He H, Yasui H, and Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 9: 127-136, 2003.
33. Shirota T, Yasui H, Shimokawa H, and Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 24: 2295-2302, 2003.
34. Sieminski AL and Gooch KJ. Biomaterial-microvasculature interactions. Biomaterials 21: 2232-2241, 2000.
35. Stock UA, Sakamoto T, Hatsuoka S, Martin DP, Nagashima M, Moran AM, Moses MA, Khalil PN, Schoen FJ, Vacanti JP, and Mayer JE Jr. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg 120: 1158-1168, 2000.
36. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, and Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012, 1997.
37. Yu Y, Flint A, Dvorin EL, and Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 277: 20711-20716, 2002.